Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism | MicrobiomeTrials← Back to trialsNCT04798469
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2022-01-10Est. Completion: 2027-09-30
Enrollment target: 150 participants Locations- Brigham and Women's Hospital, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Opioid CravingOpioid Use DisorderMeasure Development
The purpose of this study is to collect information about opioid craving so that the investigators can develop an opioid…
Baltimore, United StatesCompleted Jul 16, 2026
VAS ScoreQuadriceps Strength
This study proposes a multimodal analgesia regimen comprising preoperative non-steroidal anti-inflammatory drugs (NSAIDs…
Beijing, ChinaCompleted Jun 10, 2026